Oncology

To help clinics meet the objectives and reporting requirements of the Oncology Care Model (OCM), Flatiron Health has developed OncoEMR, a cloud-based electronic health record (EHR) coupled with an analytics tool.

A study by researchers at the University of California, Berkeley, found that patients who have access to both the prices charged by a testing laboratory as well as reference pricing, they choose lower-cost laboratories, resulting in overall cost savings.

The monoclonal antibody daratumumab (Darzalex) has been granted breakthrough designation, the second for this drug, for use in combination with either lenalidomide and dexamethasone or bortezomib and dexamethasone, for patients with multiple myeloma who have received at least 1 prior therapy.

Michael Kolodziej, MD, has joined Flatiron Health as national medical director, Managed Care Strategy.

A collaborative pilot that includes the California Department of Public Health, is studying whether near—real-time reporting of cancer diagnoses by pathologists will permit providers to make more informed and timely treatment decisions.

This week in managed care, the Department of Justice filed suit to block 2 health insurance megamergers, a poll found that healthcare is not a top issue with voters, and a study reported that patients with cancer and dementia get better end-of-life care.